Health Care

Child's Remission For HIV Gives Doctors Hope

Child's Remission For HIV Gives Doctors Hope”

Scientists believe other factors may have contributed to the child's remission, but they said this case and two others like it, one in the U.S. and one in France, may provide insight into how treating babies early could prevent them from having to take HIV drugs for their whole lives.

A 9-year-old South African child, who was born with HIV, appears to be free of the virus after receiving intense treatment at 9 weeks old.

After initial treatment as a newborn, the child (whose name has not been released) has been practically HIV-free for eight and a half years.

After 40 weeks of treatment, researchers then made a decision to stop the treatment process and place her under observation. Seventy-six per cent of people living with HIV know their HIV status, 79% of people who know their HIV-positive status have access to antiretroviral therapy and 83% of people who are on treatment have undetectable levels of HIV - this equates to 50% of all people living with HIV in Eastern and Southern Africa with viral suppression.

The four countries are among 13 nations with the highest HIV rates where PEPFAR has been focusing its efforts.

These cases may even lead to new treatments for the virus.

Although Scientists did confirm they did detect a small supply of the virus in a very small portion of immune cells, but so far they have not found evidence of an HIV infection.

At least a dozen adults also have had remissions lasting for years after stopping HIV medicines. Dr. Violari is head of pediatric research at the Perinatal HIV Research Unit, part of the University of the Witwatersrand in Johannesburg. Dr.

"We believe there may have been other factors in addition to early ART that contributed to HIV remission in this child", said Caroline Tiemessen, PhD, whose laboratory is studying the child's immune system.

Current treatments keep HIV under control but must be taken lifelong.

An ongoing NIH clinical trial called IMPAACT P1115 is testing the hypothesis that giving ART to HIV-infected newborns beginning within 48 hours of birth may permit long-term control of HIV replication after treatment is stopped, potentially leading to HIV remission. It started in 2014 in South America, Haiti, Africa and the United States, and some of the earliest participants might be able to try stopping treatment later this year.



Like this

Latest


26 July 2017
Inc. Maintains Stake in Molson Coors Brewing Company
Floating stock is calculated by subtracting closely-held shares and restricted stock from a firm's total outstanding shares. Molson Coors Brewing comprises 1.5% of Scopus Asset Management L.P.'s holdings, making the stock its 10th largest position.

26 July 2017
New Jersey Ups Smoking Age
Recent surveys show that teenagers who indulge now prefer "vaping" to cigarettes and other tobacco products. Tobacco 21 legislation is on the desks of the governors in ME and Oregon.

26 July 2017
Hecla Mining (HL) Receives News Impact Score of 0.16
Zacks Investment Research cut Hecla Mining from a "hold" rating to a "sell" rating in a research report on Wednesday, July 12th. Finally, Navellier & Associates Inc acquired a new stake in shares of Hecla Mining during the first quarter worth $310,000.

26 July 2017
Graphic Packaging Holding Company (NYSE:GPK) Reviewed By Analysts
The average twelve-month price objective among analysts that have updated their coverage on the stock in the a year ago is $15.73. BidaskClub raised shares of Graphic Packaging Holding from a "hold" rating to a "buy" rating in a report on Wednesday, July 5th.

26 July 2017
Tallahassee Ranked In The Top 10 For Most Educated Cities
The Detroit-Warren-Dearborn area came in at number 78 on the list, beating out other cities like Los Angeles and Toledo. The region ranked 32nd for its educational attainment and 69th for its quality of education and attainment gap.

26 July 2017
Biogen Inc. (NASDAQ:BIIB) Updates FY17 Earnings Guidance
It had forecast earnings of $20.45 per share to $21.25 per share and revenue of $11.1 billion to $11.4 billion in January. In looking further ahead, potential investors should note that the company's price to next year's EPS estimates is 12.65.

26 July 2017
Girl Scouts add STEM badges
But considering Girl Scouts of the United States of America is 1.8 million girls strong, those statistics could change. This will be one of the largest additions to the Girl Scouts' collection since their founding in 1912.

26 July 2017
Altuve 4 hits again, Astros rout Phillies 13-4
Bregman's home run was his 10th of the season, making him the 10th player on the team with double-digit home runs. McCann, 33, is sporting his best OPS (.778) since 2013, his final year with the Braves and the Astros are 66-33.

26 July 2017
Century-old building collapses in Kolkata, several feared trapped
It was not properly maintained as well, fire brigade officials said. They were later taken to a nearby hospital for treatment.

26 July 2017
Pembrolizumab fails to improve survival in head and neck squamous cell carcinoma
In the trials, Keytruda was being tested in combination with drugs developed by Celgene ( CELG ), including Pomalyst and Revlimid. Head and neck cancer is a catch-all for various cancers that develop in or around the throat, larynx, nose, sinuses and mouth.



Recommended